StonvexLoading…
StonvexStonvexStonvexCore line items from VREX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-03 | Q1 2026 2026-01-02 | Annual 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|
Revenue | $425.60M | $209.60M | $844.60M | $615.70M |
Operating Income | $29.80M | $15.40M | $-27.80M | $-47.40M |
Net Income | $-5.80M | $2.30M | $-70.30M | $-82.50M |
EPS (Diluted) | $-0.14 | $0.05 | $-1.70 | $-2.00 |
Total Assets | $1.09B | $1.10B | $1.11B | $1.07B |
Total Liabilities | $601.30M | $607.20M | $620.80M | $603.90M |
Cash & Equivalents | $85.30M | $119.50M | $145.00M | $136.40M |
Free Cash Flow OCF − CapEx | $-34.50M | $-26.80M | $18.80M | $16.50M |
Shares Outstanding | 42.15M | 41.92M | 41.69M | 41.52M |